Rivaroxaban versus apixaban in non‐valvular atrial fibrillation patients with end‐stage renal disease or receiving dialysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rivaroxaban versus apixaban in non‐valvular atrial fibrillation patients with end‐stage renal disease or receiving dialysis

Published:2020-01-29 Issue:4 Volume:104 Page:328-335
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Miao Benjamin¹²^ORCID,Sood Nitesh³,Bunz Thomas J.⁴,Coleman Craig I.¹²^ORCID

Affiliation:

1. University of Connecticut School of Pharmacy Storrs CT USA

2. Hartford Hospital Evidence‐Based Practice Center Hartford CT USA

3. Arrhythmia Services Southcoast Health Fall River MA USA

4. Division of Pharmacoepidemiology New England Health Analytics LLC Granby CT USA

Funder

Bayer Schering

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.13383

Reference22 articles.

1. Renal function and oral anticoagulant treatment of incident non-valvular atrial fibrillation: a retrospective study

2. Net Clinical Benefit of Antithrombotic Therapy in Patients With Atrial Fibrillation and Chronic Kidney Disease

3. Apixaban versus Warfarin in Patients with Atrial Fibrillation

4. Dabigatran versus Warfarin in Patients with Atrial Fibrillation

5. Edoxaban versus Warfarin in Patients with Atrial Fibrillation

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A real-world exploration into clinical outcomes of direct oral anticoagulant therapy in people with chronic kidney disease: a large hospital-based study;Journal of Nephrology;2024-04-02

2. Factor Xa Inhibitors Versus Vitamin K Antagonists in Atrial Fibrillation Patients with End-Stage Kidney Disease on Dialysis: A Meta-Analysis;Clinical and Applied Thrombosis/Hemostasis;2024-01

3. Efficacy and safety of direct oral anticoagulants vs vitamin K antagonists in patients with atrial fibrillation and end-stage renal disease on hemodialysis: A systematic review and meta-analysis;European Journal of Internal Medicine;2024-01

4. Comment on the 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults;Journal of the American Geriatrics Society;2023-12-23

5. Use of direct oral anticoagulants in patients on chronic hemodialysis: Contemporary appraisal on the role for patients with atrial fibrillation;Trends in Cardiovascular Medicine;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3